Characterization of the gut microbiota in leptin deficient obese mice - Correlation to inflammatory and diabetic parameters

Research in Veterinary Science

Volumn 96, Issue 2, 2014, Pages 241-250

  Ellekilde, M ^a   Krych, L ^b   Hansen, C H F ^a   Hufeldt, M R ^a,b,c   Dahl, K ^d   Hansen, L H ^b   Sorensen S J ^b   Vogensen, F K ^b   Nielsen, D S ^b   Hansen, A K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Scanbur A/S   (Denmark)

^d NOVO NORDISK A S   (Denmark)

Author keywords

Glucose intolerance; Gut microbiota; Inflammation; Obesity; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INTERLEUKIN 10; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL DNA; CYTOKINE; GLUCOSE BLOOD LEVEL; INSULIN; RNA 16S;

AKKERMANSIA MUCINIPHILA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE INTOLERANCE; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INTESTINE FLORA; LACHNOSPIRACEAE; LEPTIN DEFICIENCY; MALE; MOUSE; MOUSE MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PREVOTELLACEAE; REGULATORY T LYMPHOCYTE; VERRUCOMICROBIA; ANALYSIS; ANIMAL; BLOOD; BODY WEIGHT; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; GASTROINTESTINAL TRACT; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; IMMUNOLOGY; MICROBIOLOGY; MICROFLORA; MOUSE MUTANT; POLYMERASE CHAIN REACTION; STATISTICAL MODEL;

AKKERMANSIA MUCINIPHILA; ANIMALIA; LACHNOSPIRACEAE; MUS; PREVOTELLACEAE;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CYTOKINES; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; GASTROINTESTINAL TRACT; GLUCOSE TOLERANCE TEST; INFLAMMATION; INSULIN; LINEAR MODELS; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; MICROBIOTA; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S;

EID: 84896492510     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2014.01.007     Document Type: Article

References (51)

1. Anonymous, American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2012, 35:S64-S71.
2. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F., Gordon J.I. The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:15718-15723.
3. Bech-Nielsen G.V., Hansen C.H.F., Hufeldt M.R., Nielsen D.S., Aasted B., Vogensen F.K., Midtvedt T., Hansen A.K. Manipulation of the gut microbiota in C57BL/6 mice changes glucose tolerance without affecting weight development and gut mucosal immunity. Research in Veterinary Science 2012, 92:501-508.
4. Bleich A., Hansen A.K. Time to include the gut microbiota in the hygienic standardisation of laboratory rodents. Comparative Immunology Microbiology and Infectious Diseases 2012, 35:81-92.
5. Brun P., Castagliuolo I., Di Leo V., Buda A., Pinzani M., Palu G., Martines D. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. American Journal of Physiology Gastrointestinal and Liver Physiology 2007, 292:G518-G525.
6. Candela M., Rampelli S., Turroni S., Severgnini M., Consolandi C., De Bellis G., Masetti R., Ricci G., Pession A., Brigidi P. Unbalance of intestinal microbiota in atopic children. BMC Microbiology 2012, 12. 95-95.
7. Cani P.D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., Geurts L., Naslain D., Neyrinck A., Lambert D.M., Muccioli G.G., Delzenne N.M. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58:1091-1103.
8. Caporaso J.G., Bittinger K., Bushman F.D., DeSantis T.Z., Andersen G.L., Knight R. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 2010, 26:266-267.
9. Carey A.L., Febbraio M.A. Interleukin-6 and insulin sensitivity: friend or foe?. Diabetologia 2004, 47:1135-1142.
10. Chen P., Liu J. Metabonomics and diabetes mellitus. Advances in Therapy 2007, 24:1036-1045.
11. Christensen S.D., Mikkelsen L.F., Fels J.J., Bodvarsdottir T.B., Hansen A.K. Quality of plasma sampled by different methods for multiple blood sampling in mice. Laboratory Animals 2009, 43:65-71.
12. Collado M.C., Derrien M., Isolauri E. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Applied and Environmental Microbiology 2007, 73:7767-7770.
13. Del Chierico F., Vernocchi P., Bonizzi L., Carsetti R., Castellazzi A.M., Dallapiccola B., de Vos W., Guerzoni M.E., Manco M., Marseglia G.L., Muraca M., Roncada P., Salvatori G., Signore F., Urbani A., Putignani L. Early-life gut microbiota under physiological and pathological conditions: the central role of combined meta-omics-based approaches. Journal of Proteomics 2012, 75:4580-4587.
14. Derrien M., Collado M.C., Ben-Amor K., Salminen S., de Vos W.M. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Applied and Environmental Microbiology 2008, 74:1646-1648.
15. Ding S., Chi M.M., Scull B.P., Rigby R., Schwerbrock N.M.J., Magness S., Jobin C., Lund P.K. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 2010, 5. e12191-e12191.
16. Fujiwara D., Wei B., Presley L.L., Brewer S., McPherson M., Lewinski M.A., Borneman J., Braun J. Systemic control of plasmacytoid dendritic cells by CD8+ T cells and commensal microbiota. Journal of Immunology 2008, 180:5843-5852. (Baltimore, MD: 1950).
17. Hansen C.H.F., Krych L., Nielsen D.S., Vogensen F.K., Hansen L.H., Sorensen S.J., Buschard K., Hansen A.K. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 2012, 55:2285-2294.
18. Harris S.B., Gunion M.W., Rosenthal M.J., Walford R.L. Serum glucose, glucose-tolerance, corticosterone and free fatty-acids during aging in energy restricted mice. Mechanisms of Ageing and Development 1994, 73:209-221.
19. Holmsgaard P.N., Norman A., Hede S.C., Poulsen P.H.B., Abu Al-Soud W., Hansen L.H., Sorensen S.J. Bias in bacterial diversity as a result of Nycodenz extraction from bulk soil. Soil Biology and Biochemistry 2011, 43:2152-2159.
20. Hooper L.V., Littman D.R., Macpherson A.J. Interactions between the microbiota and the immune system. Science 2012, 336:1268-1273.
21. Hotamisligil G.S., Budavari A., Murray D., Spiegelman B.M. Reduced tyrosine kinase-activity of the insulin-receptor in obesity-diabetes - Central role of tumor-necrosis-factor-alpha. Journal of Clinical Investigation 1994, 94:1543-1549.
22. Hufeldt M.R., Nielsen D.S., Vogensen F.K., Midtvedt T., Hansen A.K. Family relationship of female breeders reduce the systematic inter-intervidual variation in the gut microbiota of inbred laboratory mice. Laboratory Animals 2010, 44:283-289.
23. Hufeldt M.R., Nielsen D.S., Vogensen F.K., Midtvedt T., Hansen A.K. Variation in the gut microbiota of laboratory mice is related to both genetic and environmental factors. Comparative Medicine 2010, 60:336-342.
24. Haas B.J., Gevers D., Earl A.M., Feldgarden M., Ward D.V., Giannoukos G., Ciulla D., Tabbaa D., Highlander S.K., Sodergren E., Methe B., DeSantis T.Z., Petrosino J.F., Knight R., Birren B.W., Human Microbiome C. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Research 2011, 21:494-504.
25. Karlsson H., Hessle C., Rudin A. Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infection and Immunity 2002, 70:6688-6696.
26. Kelly D., King T., Aminov R. Importance of microbial colonization of the gut in early life to the development of immunity. Mutation Research Fundamental and Molecular Mechanisms of Mutagenesis 2007, 622:58-69.
27. Kern P.A., Ranganathan S., Li C.L., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. American Journal of Physiology Endocrinology and Metabolism 2001, 280:E745-E751.
28. Krych L., Hansen C.H.F., Hansen A.K., van den Berg F.W.J., Nielsen D.S. Quantitatively different, yet qualitatively alike: a meta-analysis of the mouse core gut microbiome with a view towards the human gut microbiome. PLoS One 2013, 8(5):e62578.
29. Larsen N., Vogensen F.K., van d.B., Nielsen D.S., Andreasen A.S., Pedersen B.K., Abu Al-Soud W., Sorensen S.J., Hansen L.H., Jakobsen M. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. Plos One 2010, 5(2):e9085.
30. Lauritsen L.F.S., Hufeldt M.R., Aasted B., Hansen C.H.F., Midtvedt T., Buschard K., Hansen A.K. The impact of a germ free perinatal period on the variation in animal models of human inflammatory diseases - a review. Scandinavian Journal of Laboratory Animal Science 2010, 37:43-54.
31. Liu T., Hougen H., Vollmer A.C., Hiebert S.M. Gut bacteria profiles of Mus musculus at the phylum and family levels are influenced by saturation of dietary fatty acids. Anaerobe 2012, 18:331-337.
32. McKnite A.M., Perez-Munoz M.E., Lu L., Williams E.G., Brewer S., Andreux P.A., Bastiaansen J.W.M., Wang X., Kachman S.D., Auwerx J., Williams R.W., Benson A.K., Peterson D.A., Ciobanu D.C. Murine gut microbiota is defined by host genetics and modulates variation of metabolic traits. PLoS One 2012, 7. e39191-e39191.
33. Membrez M., Blancher F., Jaquet M., Bibiloni R., Cani P.D., Burcelin R.G., Corthesy I., Mace K., Chou C. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB Journal 2008, 22:2416-2426.
34. Mizoguchi A., Mizoguch E. Inflammatory bowel disease, past, present and future: lessons from animal models. Journal of Gastroenterology 2008, 43:1-17.
35. Muyzer G., Dewaal E.C., Uitterlinden A.G. Profiling of complex microbial-populations by denaturing gradient gel-electrophoresis analysis of polymerase chain reaction-amplified genes-coding for 16S ribosomal-Rna. Applied and Environmental Microbiology 1993, 59:695-700.
36. Nathan D.M., Balkau B., Bonora E., Borch-Johnsen K., Buse J.B., Colagiuri S., Davidson M.B., DeFronzo R., Genuth S., Holman R.R., Ji L., Kirkman S., Knowler W.C., Schatz D., Shaw J., Sobngwi E., Steffes M., Vaccaro O., Wareham N., Zinman B., Kahn R., Int Expert C. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334.
37. Nicklas W., Baneux P., Boot R., Decelle T., Deeny A., Fumanelli M., Illgen-Wilcke B. Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Laboratory Animals 2002, 36:20-42.
38. Norio E., Midtvedt T. Intestinal microflora functions in laboratory mice claimed to harbor a "normal" intestinal microflora. Is the SPF concept running out of date?. Anaerobe 2010, 16:311-313.
39. Png C.W., Linden S.K., Gilshenan K.S., Zoetendal E.G., McSweeney C.S., Sly L.I., McGuckin M.A., Florin T.H.J. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. American Journal of Gastroenterology 2010, 105:2420-2428.
40. Reshef D.N., Reshef Y.A., Finucane H.K., Grossman S.R., McVean G., Turnbaugh P.J., Lander E.S., Mitzenmacher M., Sabeti P.C. Detecting novel associations in large data sets. Science 2011, 334:1518-1524.
41. Riserus U., Willett W.C., Hu F.B. Dietary fats and prevention of type 2 diabetes. Progress in Lipid Research 2009, 48:44-51.
42. Romagnani S. The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?. Immunology 2004, 112:352-363.
43. Stachebrandt E., Goodfellow M. Nucleic Acid Techniques in Bacterial Systematics 1991, John Wiley and Son Ltd., p. 329.
44. Tlaskalova-Hogenova H., Stepankova R., Hudcovic T., Tuckova L., Cukrowska B., Lodinova-Zadnikova R., Kozakova H., Rossmann P., Bartova J., Sokol D., Funda D.P., Borovska D., Rehakova Z., Sinkora J., Hofman J., Drastich P., Kokesova A. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunology Letters 2004, 93:97-108.
45. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
46. Uysal K.T., Wiesbrock S.M., Hotamisligil G.S. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity. Endocrinology 1998, 139:4832-4838.
47. Varga O., Harangi M., Olsson I.A.S., Hansen A.K. Contribution of animal models to the understanding of the metabolic syndrome: a systematic overview. Obesity Reviews 2010, 11:792-807.
48. Wang L., Christophersen C.T., Sorich M.J., Gerber J.P., Angley M.T., Conlon M.A. Low relative abundances of the mucolytic bacterium akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Applied and Environmental Microbiology 2011, 77:6718-6721.
49. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003, 112:1796-1808.
50. Yu Y., Lee C., Kim J., Hwang S. Group-specific primer and probe sets to detect methanogenic communities using quantitative real-time polymerase chain reaction. Biotechnology and Bioengineering 2005, 89:670-679.
51. Zhang H., DiBaise J.K., Zuccolo A., Kudrna D., Braidotti M., Yu Y., Parameswaran P., Crowell M.D., Wing R., Rittmann B.E., Krajmalnik-Brown R. Human gut microbiota in obesity and after gastric bypass. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:2365-2370.